ArticleNPJ precision oncology2025

Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer.

Lisa Paschold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.